Furthermore, high levels of IL-1β in tumors and serum were associated with higher tumor grades and increased invasion of breast, pancreatic cancer, and myelogenous leukemia, and were also associated with poor prognosis (Setrerrahmane and Xu 2017). This evidence concerns the gene IL1B and familial pancreatic carcinoma.